Cytomx Therapeutics Inc buy BiotechBee
Start price
02.05.24
/
70%
€4.18
Target price
28.06.26
€50.00
Performance (%)
-72.57%
Price
22:26
€1.15
Summary
This prediction is currently active. The BUY prediction by BiotechBee for Cytomx Therapeutics Inc is performing very badly with a performance of -72.57%. This prediction currently runs until 28.06.26. The prediction end date can be changed by BiotechBee at any time. BiotechBee has 70% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Cytomx Therapeutics Inc | -9.441% | -9.441% |
iShares Core DAX® | -3.935% | -3.998% |
iShares Nasdaq 100 | -3.608% | -9.386% |
iShares Nikkei 225® | -4.513% | -8.017% |
iShares S&P 500 | -2.607% | -4.265% |
According to BiotechBee what are the pros and cons of Cytomx Therapeutics Inc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Cytomx Therapeutics Inc diskutieren
Buy mit Kursziel 50,0
Stopped prediction by BiotechBee for Cytomx Therapeutics Inc
Cytomx Therapeutics Inc
Start price
Target price
Perf. (%)
€2.59
06.02.23
06.02.23
€4.00
31.12.25
31.12.25
-40.15%
05.05.23
05.05.23
Could be very worthwhile Investment >20% year
Cytomx Therapeutics Inc
Start price
Target price
Perf. (%)
€1.73
05.01.23
05.01.23
€3.00
31.12.25
31.12.25
37.80%
06.01.23
06.01.23
Could be very worthwhile Investment >20% year